Novoeight and Tofacitinib Extended-Release Tablets
Determining the interaction of Novoeight and Tofacitinib Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Novoeight (recombinant)
Generic Name: tofacitinib
Brand name: Xeljanz, Xeljanz XR
Synonyms: Tofacitinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Novoeight-Tofacitinib Tablets
- Novoeight-Tofranil
- Novoeight-Tofranil injection
- Novoeight-Tofranil-PM
- Novoeight-Tol-Tab
- Novoeight-Tolazamide
- Tofacitinib Extended-Release Tablets-Novoeight recombinant
- Tofacitinib Extended-Release Tablets-Novolin 70/30
- Tofacitinib Extended-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills))
- Tofacitinib Extended-Release Tablets-Novolin 70/30 (Insulin NPH and Insulin Regular (Vials))
- Tofacitinib Extended-Release Tablets-Novolin N
- Tofacitinib Extended-Release Tablets-Novolin N (Insulin NPH (InnoLets, Pens, and PenFill Cartridges))